Stones: Gut microbiome is unique in kidney stone disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Probiotics in the prevention and treatment of calcium oxalate kidney stones: mechanisms and therapeutic potential.Frontiers in microbiology · 2025
   Review
2. Association of dietary patterns with gut microbiota in kidney stone and non-kidney stone individuals.Urolithiasis · 2022
   Article
3. Characterization of the Genitourinary Microbiome of 1,165 Middle-Aged and Elderly Healthy Individuals.Frontiers in microbiology · 2021
   Article
4. Oxalate Alters Cellular Bioenergetics, Redox Homeostasis, Antibacterial Response, and Immune Response in Macrophages.Frontiers in immunology · 2021
   Article
5. Urolithiasis · 2020
   Article
6. Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases.Frontiers in microbiology · 2016
   Review

Corrections and comments

• Comment on
  Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.2016

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as